The Food and Drug Administration is reversing course on its requirement for all staffers to report to the office ...

The letter, addressed to Senate Health, Education, Labor and Pensions Committee (HELP) chair Bill Cassidy, R-IL, is written and supported by 207 biotech innovators, including industry heavyweights ...

Biotech leaders urge Senate intervention as FDA restructuring risks expertise loss impacting operations. Read more here.